IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1728-1736

  Mejías Luque, Raquel ^a   Peiró, Sandra ^a   Vincent, Audrey ^b   Van Seuningen, Isabelle ^b   de Bolós, Carme ^a  

^a HOSPITAL DEL MAR   (Spain)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

Author keywords

Gastric cell; IL 6; MUC4; Mucin; STAT3

Indexed keywords

CIS ACTING ELEMENT; GLYCOPROTEIN GP 130; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; MUCIN 2; MUCIN 4; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN;

ARTICLE; BAY REGION BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CYTOKINE RECEPTOR GP130; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MUCINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 51049086846     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.05.020     Document Type: Article

References (43)

1. Correa P., Piazuelo M.B., and Camargo M.C. The future of gastric cancer prevention. Gastric.Cancer 7 (2004) 9-16
2. Fox J.G., and Wang T.C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest 117 (2007) 60-69
3. Crabtree J.E., Shallcross T.M., Heatley R.V., and Wyatt J.I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32 (1991) 1473-1477
4. Furukawa K., Takahashi T., Arai F., Matsushima K., and Asakura H. Enhanced mucosal expression of interleukin-6 mRNA but not of interleukin-8 mRNA at the margin of gastric ulcer in Helicobacter pylori-positive gastritis. J. Gastroenterol. 33 (1998) 625-633
5. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
6. Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res. 13 (2007) 1362-1366
7. de Bolos C., Garrido M., and Real F.X. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109 (1995) 723-734
8. Ho S.B., Roberton A.M., Shekels L.L., Lyftogt C.T., Niehans G.A., and Toribara N.W. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 109 (1995) 735-747
9. Reis C.A., David L., Correa P., Carneiro F., de Bolos C., Garcia E., Mandel U., Clausen H., and Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 59 (1999) 1003-1007
10. Lopez-Ferrer A., de Bolos C., Barranco C., Garrido M., Isern J., Carlstedt I., Reis C.A., Torrado J., and Real F.X. Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 47 (2000) 349-356
11. Porchet N., Nguyen V.C., Dufosse J., Audie J.P., Guyonnet-Duperat V., Gross M.S., Denis C., Degand P., Bernheim A., and Aubert J.P. Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun. 175 (1991) 414-422
12. Moniaux N., Nollet S., Porchet N., Degand P., Laine A., and Aubert J.P. Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem. J. 338 Pt 2 (1999) 325-333
13. Nollet S., Moniaux N., Maury J., Petitprez D., Degand P., Laine A., Porchet N., and Aubert J.P. Human mucin gene MUC4: organization of its 5¢-region and polymorphism of its central tandem repeat array. Biochem. J. 332 Pt 3 (1998) 739-748
14. Balague C., Audie J.P., Porchet N., and Real F.X. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 109 (1995) 953-964
15. Chaturvedi P., Singh A.P., Moniaux N., Senapati S., Chakraborty S., Meza J.L., and Batra S.K. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol. Cancer Res. 5 (2007) 309-320
16. Lopez-Ferrer A., Alameda F., Barranco C., Garrido M., and de Bolos C. MUC4 expression is increased in dysplastic cervical disorders. Hum. Pathol. 32 (2001) 1197-1202
17. Alameda F., Mejias-Luque R., Garrido M., and de Bolos C. Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues. Int. J. Gynecol. Pathol. 26 (2007) 61-65
18. Vollmers H.P., Stulle K., Dammrich J., Pfaff M., Papadopoulos T., Betz C., Saal K., and Muller-Hermelink H.K. Characterization of four new gastric cancer cell lines. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 63 (1993) 335-343
19. Gartner F., David L., Seruca R., Machado J.C., and Sobrinho-Simoes M. Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch. 428 (1996) 91-98
20. Lopez-Ferrer A., Curull V., Barranco C., Garrido M., Lloreta J., Real F.X., and de Bolos C. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am. J. Respir. Cell Mol. Biol. 24 (2001) 22-29
21. Hanukoglu I., Tanese N., and Fuchs E. Complementary DNA sequence of a human cytoplasmic actin. Interspecies divergence of 3¢ non-coding regions. J. Mol. Biol. 163 (1983) 673-678
22. Piessen G., Jonckheere N., Vincent A., Hemon B., Ducourouble M.P., Copin M.C., Mariette C., and Van I S. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. Biochem. J. 402 (2007) 81-91
23. Perrais M., Pigny P., Ducourouble M.P., Petitprez D., Porchet N., Aubert J.P., and Van I S. Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. J. Biol. Chem 276 (2001) 30923-30933
24. Peiro S., Escriva M., Puig I., Barbera M.J., Dave N., Herranz N., Larriba M.J., Takkunen M., Franci C., Munoz A., Virtanen I., Baulida J., and Garcia d.H. Snail1 transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res. 34 (2006) 2077-2084
25. Mesquita P., Jonckheere N., Almeida R., Ducourouble M.P., Serpa J., Silva E., Pigny P., Silva F.S., Reis C., Silberg D., Van I S., and David L. Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J. Biol. Chem 278 (2003) 51549-51556
26. Carvalho F., David L., Aubert J.P., Lopez-Ferrer A., de Bolos C., Reis C.A., Gartner F., Peixoto A., Alves P., and Sobrinho-Simoes M. Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines. Virchows Arch. 435 (1999) 479-485
27. Huang C., Cao J., Huang K.J., Zhang F., Jiang T., Zhu L., and Qiu Z.J. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci. 97 (2006) 1417-1423
28. de Bolos C., Real F.X., and Lopez-Ferrer A. Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors. Front Biosci. 6 (2001) D1256-D1263
29. Almeida R., Silva E., Santos-Silva F., Silberg D.G., Wang J., de Bolos C., and David L. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J. Pathol. 199 (2003) 36-40
30. Silberg D.G., Furth E.E., Taylor J.K., Schuck T., Chiou T., and Traber P.G. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113 (1997) 478-486
31. Silberg D.G., Sullivan J., Kang E., Swain G.P., Moffett J., Sund N.J., Sackett S.D., and Kaestner K.H. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122 (2002) 689-696
32. Velcich A., Palumbo L., Selleri L., Evans G., and Augenlicht L. Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus. J. Biol. Chem. 272 (1997) 7968-7976
33. Andrianifahanana M., Singh A.P., Nemos C., Ponnusamy M.P., Moniaux N., Mehta P.P., Varshney G.C., and Batra S.K. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene (2007)
34. Carraway III K.L., Funes M., Workman H.C., and Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr. Top. Dev. Biol 78 (2007) 1-22
35. Wu C.W., Wang S.R., Chao M.F., Wu T.C., Lui W.Y., P'eng F.K., and Chi C.W. Serum interleukin-6 levels reflect disease status of gastric cancer. Am. J. Gastroenterol. 91 (1996) 1417-1422
36. Lin M.T., Lin B.R., Chang C.C., Chu C.Y., Su H.J., Chen S.T., Jeng Y.M., and Kuo M.L. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int. J. Cancer 120 (2007) 2600-2608
37. Levy D.E., and Lee C.K. What does Stat3 do?. J. Clin. Invest 109 (2002) 1143-1148
38. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B., Waring P., Clay F.J., Malki S., Alderman B.M., Grail D., Hollande F., Heath J.K., and Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8 (2002) 1089-1097
39. Jenkins B.J., Grail D., Nheu T., Najdovska M., Wang B., Waring P., Inglese M., McLoughlin R.M., Jones S.A., Topley N., Baumann H., Judd L.M., Giraud A.S., Boussioutas A., Zhu H.J., and Ernst M. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat. Med. 11 (2005) 845-852
40. Judd L.M., Bredin K., Kalantzis A., Jenkins B.J., Ernst M., and Giraud A.S. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131 (2006) 1073-1085
41. Bromberg J. Stat proteins and oncogenesis. J. Clin. Invest 109 (2002) 1139-1142
42. Gong W., Wang L., Yao J.C., Ajani J.A., Wei D., Aldape K.D., Xie K., Sawaya R., and Huang S. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin. Cancer Res. 11 (2005) 1386-1393
43. Jackson C.B., Judd L.M., Menheniott T.R., Kronborg I., Dow C., Yeomans N.D., Boussioutas A., Robb L., and Giraud A.S. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J. Pathol. 213 (2007) 140-151